A regulatory amendment rarely affects only one line of a formula. Replacing an ingredient can change stability, microbiology, performance, claims, packaging and the full regulatory dossier.
Assess the legal deadline and portfolio scope
First establish the application date, transitional provisions and distinction between placing on the market and making a product available. Then identify every product, market and raw material affected.
The inventory should cover direct use of the substance and possible sources within mixtures. Suppliers need early contact to confirm composition and future material availability.
Select and screen the replacement
A replacement must meet functional, sensory, process and packaging needs while complying with current regulatory conditions. Early screening avoids developing a formula that creates another compliance problem.
Restrictions, impurities, allergens, nano status, CMR status and possible effect on product classification are reviewed. Any commercial claim for the replacement requires separate substantiation assessment.
Practical checkpoint
Every conclusion should be linked to the exact formula, document and market-material version. This makes it possible to demonstrate which evidence supported the regulatory decision.
Plan repeat testing
A change may affect stability, pH, viscosity, preservation, packaging compatibility, odour, colour and performance. Testing is based on the size and risk of the change, not on whether the formula appears similar.
Laboratory lead times should be aligned with manufacturing and packaging inventory. An unrealistic schedule can force decisions without sufficient evidence.
Update the regulatory dossier
The new formula requires a safety impact assessment and, where necessary, an updated CPSR. The PIF, raw-material files, specifications, manufacturing process, claims, label and CPNP must all follow the same version.
The change-control record should contain rationale, approvals, affected documents and the implementation date. Old and new versions must be clearly separated in manufacturing and distribution.
Manage packaging and market transition
When the INCI list or a claim changes, existing packaging may no longer be suitable for the new formula. Planning should connect stock depletion, final production of the old formula and first placement of the new version.
Sale-through depends on the specific transitional rules and evidence. Regulatory, marketing and logistics teams should use one approved timeline.
Frequently asked questions
Is every ingredient replacement a new product version?
The regulatory effect varies, but the formula and related documents should always receive a controlled new version.
Must the challenge test be repeated?
If the change could affect microbiological robustness, preservative efficacy needs assessment and often renewed evidence.
Can old packaging be used with the new formula?
Only if every particular, precaution, INCI entry and claim remains correct for the new version.
Official sources and further reading
This article is for general information and does not replace an assessment of the specific product, formula and supply chain. Legislation and guidance may change after publication.